Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma - Related Studies

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

This study is currently recruiting participants.

Study NCT00324727. Last updated on October 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Intraocular Melanoma
		Melanoma (Skin)
		Metastatic Cancer

2	Additional conditions recognized in this trial
		Eye Neoplasms
		Melanoma
		Neoplasm Metastasis

3	More general conditions related to this trial
		Eye Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neoplastic Processes
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Pathologic Processes

4	Interventions listed in this trial
		melphalan
		hepatic artery embolization
		regional chemotherapy
		systemic chemotherapy

5	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)